Immunization, Hib3 in Pre-demographic dividend
Pre-demographic dividend: Immunization, Hib3 was 72.9% in 2024. ◆ Volatile
Immunization, Hib3 in Pre-demographic dividend, 1990–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
Pre-demographic dividend recorded 72.9% for immunization, hib3 in 2024.
Compared with earlier readings it is down 0.2% on the previous year and up 6.3% over ten years.
Over the whole period, immunization, hib3 in Pre-demographic dividend peaked at 76.4% in 2019 and was at its lowest, 0.0%, in 1990.
That places Pre-demographic dividend 37th out of 43 groups with data for 2024, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Immunization, Hib3 in Pre-demographic dividend, year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 1990 | 0.0% | — |
| 1991 | 0.0% | — |
| 1992 | 0.0% | — |
| 1993 | 0.0% | — |
| 1994 | 0.0% | — |
| 1995 | 0.0% | — |
| 1996 | 0.0% | — |
| 1997 | 0.0% | — |
| 1998 | 0.3% | — |
| 1999 | 0.2% | -4.1% |
| 2000 | 0.2% | -5.4% |
| 2001 | 0.2% | -4.9% |
| 2002 | 7.3% | +3196.0% |
| 2003 | 7.9% | +7.5% |
| 2004 | 11.4% | +44.5% |
| 2005 | 12.6% | +10.2% |
| 2006 | 16.6% | +32.4% |
| 2007 | 20.0% | +20.1% |
| 2008 | 27.5% | +37.5% |
| 2009 | 53.9% | +95.9% |
| 2010 | 53.7% | -0.3% |
| 2011 | 54.9% | +2.1% |
| 2012 | 58.9% | +7.4% |
| 2013 | 63.8% | +8.2% |
| 2014 | 68.6% | +7.6% |
| 2015 | 68.9% | +0.4% |
| 2016 | 72.1% | +4.7% |
| 2017 | 72.7% | +0.8% |
| 2018 | 75.1% | +3.3% |
| 2019 | 76.4% | +1.8% |
| 2020 | 73.1% | -4.4% |
| 2021 | 71.6% | -1.9% |
| 2022 | 72.2% | +0.7% |
| 2023 | 73.1% | +1.3% |
| 2024 | 72.9% | -0.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 0.1% | 0.0% | 0.3% | 10 |
| 2000s | 15.8% | 0.2% | 53.9% | 10 |
| 2010s | 66.5% | 53.7% | 76.4% | 10 |
| 2020s | 72.6% | 71.6% | 73.1% | 5 |
More health data for Pre-demographic dividend
- Population ages 30-34, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, female, annual growth rate 3.24 % change on previous year (2025)
- Population ages 35-39, male, per capita 0.0271 units per person (2025)
- Population ages 35-39, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, male, annual growth rate 3.03 % change on previous year (2025)
- Population ages 35-39, female, per capita 0.0276 units per person (2025)
- Population ages 35-39, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, female, annual growth rate 2.97 % change on previous year (2025)
- Population ages 30-34, male, per capita 0.0326 units per person (2025)
- Population ages 25-29, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is immunization, hib3 in Pre-demographic dividend?
- Immunization, hib3 in Pre-demographic dividend was 72.9% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in Pre-demographic dividend?
- The highest recorded value was 76.4% in 2019.
- What is the lowest immunization, hib3 recorded in Pre-demographic dividend?
- The lowest recorded value was 0.0% in 1990.
- How does Pre-demographic dividend rank for immunization, hib3?
- Pre-demographic dividend ranks 37th out of 43 groups with data for 2024.
- Is immunization, hib3 rising or falling in Pre-demographic dividend?
- Over the last ten years it is up 6.3%. The long-run trend across the full record is volatile.
- Where does this Pre-demographic dividend data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 35 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.